Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models-Reference-Cited by-同舟云学术

Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models

Published:2015-02-23 Issue:2 Volume:10 Page:e0116678
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Brendel Matthias,Jaworska Anna,Grießinger Eric,Rötzer Christina,Burgold Steffen,Gildehaus Franz-Josef,Carlsen Janette,Cumming Paul,Baumann Karlheinz,Haass Christian,Steiner Harald,Bartenstein Peter,Herms Jochen,Rominger Axel

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Alzheimer disease pharmacologic treatment and treatment research;LS Schneider;Continuum (Minneap Minn),2013

2. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association;KA Johnson;J Nucl Med,2013

3. Longitudinal assessment of cerebral beta-amyloid deposition in mice overexpressing Swedish mutant beta-amyloid precursor protein using 18F-florbetaben PET;A Rominger;J Nucl Med,2013

4. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s disease;A Manook;PLoS One,2012

5. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease;C Kuntner;Mol Imaging Biol,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice;Frontiers in Neuroscience;2022-08-05

2. PET Imaging in Preclinical Anti-Aβ Drug Development;Pharmaceutical Research;2022-05-02

3. Preclinical Longitudinal In Vivo Biomarker Platform for Alzheimer’s Disease Drug Discovery;Alzheimer's Disease Drug Development;2022-03-31

4. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition;Frontiers in Aging Neuroscience;2022-03-30

5. Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications;Pharmaceuticals;2021-11-18